# A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

Source: https://onco.cc/trials/nct07533123/  
OnCo record `nct07533123` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial testing JSKN016 in triple-negative breast cancer, now recruiting.

## Summary

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care is a phase 3 interventional study registered as NCT07533123, led by Jiangsu Alphamab Biopharmaceuticals, and recruiting on the registry. Official title: A Randomised, Controlled, Open-Label Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Triple-Negative Breast Cancer Who Have Failed at Least Two Lines of Prior Systemic Therapy. Planned enrolment is 364 participants (estimated). The study started in 2026-03-17 and primary completion is expected in 2029-03-17. No results have been posted on ClinicalTrials.gov.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-11
- Tags: ctgov-ingest
- Registry id: NCT07533123
- Phase: 3
- Setting: A Randomized, Controlled, Open-Label Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Triple-Negative Breast Cancer Who Have Failed at Least Two Lines of Prior Systemic Therapy
- Sponsor: Jiangsu Alphamab Biopharmaceuticals
- Enrolled: 364

## Sources

- ClinicalTrials.gov NCT07533123: https://clinicaltrials.gov/study/NCT07533123

## Connected records

- cancers: [Metastatic triple-negative breast cancer](https://onco.cc/cancers/tnbc-metastatic/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- drugs: [JSKN016](https://onco.cc/drugs/jskn016/)
- companies: [Alphamab Oncology](https://onco.cc/companies/alphamab/)

---
JSON: https://onco.cc/api/v1/entities/nct07533123.json